Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11618894 Bacteria engineered to reduce hyperphenylalaninemia

Patent 11618894 was granted and assigned to Synlogic on April, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11618894 Bacteria engineered to reduce hyperphenylalaninemia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo